156 related articles for article (PubMed ID: 37182650)
21. An update on thyroid-associated ophthalmopathy in children and adolescents.
Szczapa-Jagustyn J; Gotz-Więckowska A; Kocięcki J
J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1115-1122. PubMed ID: 27682712
[TBL] [Abstract][Full Text] [Related]
22. Grave's ophthalmopathy (GO), are the extrathyroidal manifestations of Grave's disease. Foreword.
Krassas GE; Bartalena L; Benbassat C
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():173. PubMed ID: 20509231
[No Abstract] [Full Text] [Related]
23. Painful Diplopia: Do Not Forget Thyroid-Associated Ophthalmopathy.
Mavridis T; Velonakis G; Zouvelou V
Am J Med; 2021 Apr; 134(4):e239-e240. PubMed ID: 32931761
[No Abstract] [Full Text] [Related]
24. Natural history of Graves' Ophthalmopathy.
Benbassat CA; Robenshtok E
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():174-7. PubMed ID: 20467358
[TBL] [Abstract][Full Text] [Related]
25. A symposium on thyroid-associated ophthalmopathy, also known as Graves' orbitopathy at the Jules Stein Eye Institute at the University of California, Los Angeles.
Douglas RS; Goldberg RA; Smith TJ
Thyroid; 2008 Sep; 18(9):931. PubMed ID: 18788916
[No Abstract] [Full Text] [Related]
26. Optimal management of Graves orbitopathy: a multidisciplinary approach.
Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
[TBL] [Abstract][Full Text] [Related]
27. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
Krassas GE; Segni M; Wiersinga WM
Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
[TBL] [Abstract][Full Text] [Related]
28. [Therapy-resistant thyroid diseases. 1.Graves' ophthalmopathy].
Hiromatsu Y
Nihon Naika Gakkai Zasshi; 2010 Apr; 99(4):755-62. PubMed ID: 20578362
[No Abstract] [Full Text] [Related]
29. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.
Träisk F; Tallstedt L; Abraham-Nordling M; Andersson T; Berg G; Calissendorff J; Hallengren B; Hedner P; Lantz M; Nyström E; Ponjavic V; Taube A; Törring O; Wallin G; Asman P; Lundell G;
J Clin Endocrinol Metab; 2009 Oct; 94(10):3700-7. PubMed ID: 19723755
[TBL] [Abstract][Full Text] [Related]
30. Asymmetric Graves' Orbitopathy.
Panagiotou G; Perros P
Front Endocrinol (Lausanne); 2020; 11():611845. PubMed ID: 33391188
[TBL] [Abstract][Full Text] [Related]
31. Extrathyroidal manifestations of thyroid disease: thyroid ophthalmopathy.
Parmar H; Ibrahim M
Neuroimaging Clin N Am; 2008 Aug; 18(3):527-36, viii-ix. PubMed ID: 18656033
[TBL] [Abstract][Full Text] [Related]
32. The diagnosis and treatment of thyroid-associated ophthalmopathy.
Gould DJ; Roth FS; Soparkar CN
Aesthetic Plast Surg; 2012 Jun; 36(3):638-48. PubMed ID: 22083413
[TBL] [Abstract][Full Text] [Related]
33. Euthyroid Graves' ophthalmopathy with negative autoantibodies.
Cakir M
J Natl Med Assoc; 2005 Nov; 97(11):1547-9. PubMed ID: 16334503
[TBL] [Abstract][Full Text] [Related]
34. 2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease.
Hoang TD; Stocker DJ; Chou EL; Burch HB
Endocrinol Metab Clin North Am; 2022 Jun; 51(2):287-304. PubMed ID: 35662442
[TBL] [Abstract][Full Text] [Related]
35. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
[TBL] [Abstract][Full Text] [Related]
36. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
Brammen L; Riss P; Lukas J; Gessl A; Dunkler D; Li S; Leisser A; Rezar-Dreindl S; Eibenberger K; Selberherr A; Scheuba C; Papp A
Trials; 2018 Sep; 19(1):495. PubMed ID: 30219088
[TBL] [Abstract][Full Text] [Related]
37. The American Thyroid Association/American Association of Clinical Endocrinologists guidelines for hyperthyroidism and other causes of thyrotoxicosis: a European perspective.
Kahaly GJ; Bartalena L; Hegedüs L
Thyroid; 2011 Jun; 21(6):585-91. PubMed ID: 21663420
[No Abstract] [Full Text] [Related]
38. Medical treatment in thyroid eye disease in 2020.
Khong JJ; McNab A
Br J Ophthalmol; 2021 Mar; 105(3):299-305. PubMed ID: 32447327
[TBL] [Abstract][Full Text] [Related]
39. Atypical Presentation of Hashimoto's Disease in an Adolescent: Thyroid-Associated Ophthalmopathy.
Kırmızıbekmez H; Yeşiltepe Mutlu RG
J Clin Res Pediatr Endocrinol; 2014 Dec; 6(4):262-5. PubMed ID: 25541900
[TBL] [Abstract][Full Text] [Related]
40. The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds.
Zhyzhneuskaya S; Addison C; Tsatlidis V; Weaver JU; Razvi S
Thyroid; 2016 Jun; 26(6):765-9. PubMed ID: 27090092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
